<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="55286">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01850732</url>
  </required_header>
  <id_info>
    <org_study_id>AAA-03</org_study_id>
    <nct_id>NCT01850732</nct_id>
  </id_info>
  <brief_title>Screening of Abdominal Aortic Aneurysms Among Male Patients With TIA Symptoms</brief_title>
  <official_title>Screening of Abdominal Aortic Aneurysms Among Male Patients With TIA Symptoms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>North Karelia Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>North Karelia Central Hospital</source>
  <oversight_info>
    <authority>Finland: Ethics Committee</authority>
    <authority>Finland: Valvira - National Supervisory Authority for Welfare and Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the prevalence of abdominal aortic aneurysms
      (AAA) among male patients with transient ischemic attack (TIA) symptoms. Ethiology of AAA is
      known to be common with atherosclerotic arterial diseases (coronary artery disease,
      peripheral artery disease and carotid artery disease), so the hypothesis is that AAA should
      be more common among these TIA patients, thus making screening of these patients (for AAA)
      more cost-efficient.

      Study will be carried out as a prospective screening study. Data will be collected in North
      Karelia Central Hospital within one year. All male patients with TIA symptoms will be
      recruited for the study and screened for AAA with ultrasound.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Primary Purpose: Screening</study_design>
  <primary_outcome>
    <measure>Maximum diameter (mm) of abdominal aorta (outer-to-outer wall) in ultrasound</measure>
    <time_frame>upon screening (collection of data will take one year)</time_frame>
  </primary_outcome>
  <condition>Abdominal Aortic Aneurysm</condition>
  <arm_group>
    <arm_group_label>ultrasound of aorta</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ultrasound of aorta</intervention_name>
    <arm_group_label>ultrasound of aorta</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male patient who has had symptoms of transient ischemic attack (TIA)

        Exclusion Criteria:

          -  Patient's denial to participate

          -  Female gender

          -  Already diagnosed or treated abdominal aortic aneurysm
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Ville V채nni, MD</last_name>
    <phone>+358405349669</phone>
    <email>ville.vanni@pkssk.fi</email>
  </overall_contact>
  <location>
    <facility>
      <name>North Carelia Central Hospital</name>
      <address>
        <city>Joensuu</city>
        <state>Pohjois-Karjala</state>
        <zip>80200</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>V채nni</last_name>
      <email>ville.vanni@pkssk.fi</email>
    </contact>
    <investigator>
      <last_name>Ville V채nni, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 9, 2013</lastchanged_date>
  <firstreceived_date>May 7, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>North Karelia Central Hospital</investigator_affiliation>
    <investigator_full_name>Ville V채nni</investigator_full_name>
    <investigator_title>General surgeon</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
